Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
NewLink inks deal with AstraZeneca to test Imfinzi combo
BioPharma Dive
Thu, 09/28/17 - 09:57 am
NewLink Genetics
AstraZeneca
Imfinzi
indoximod
metastatic pancreatic cancer
AstraZeneca's latest respiratory win could spur Bevespi approvals in China, Japan
Fierce Pharma
Wed, 09/27/17 - 11:29 am
AstraZeneca
Bevespi
COPD
China
Japan
AstraZeneca's Bydureon fails to show cardio-protection
BioPharma Dive
Thu, 09/14/17 - 10:05 pm
EASD
AstraZeneca
Bydureon
diabetes
AstraZeneca's latest sale rakes in $555M
BioPharma Dive
Thu, 09/14/17 - 06:58 pm
AstraZeneca
M&A
Diprivan
Naropin
Carbocaine
Aspen Global
EASD: AstraZeneca's Farxiga cuts blood sugar, weight and insulin use in Type 1 study
Fierce Pharma
Thu, 09/14/17 - 09:56 am
EASD
AstraZeneca
Farixga
diabetes
AstraZeneca and Moderna take a big, early step forward in their quest to prove mRNA works in humans
Endpoints
Thu, 09/14/17 - 09:52 am
AstraZeneca
Moderna
MRNA
AZD-8601
AstraZeneca's Asthma Candidate Shows Promising Results
Yahoo/Zacks.com
Wed, 09/13/17 - 09:27 am
AstraZeneca
asthma
benralizumab
AstraZeneca CEO, worried by Brexit, not signing UK government letter
Yahoo/Reuters
Sun, 09/10/17 - 12:05 pm
AstraZeneca
UK
Brexit
Pharma CEOs
Pascal Soriot
ESMO: AstraZeneca wows with Imfinzi's 11-month survival edge in lung cancer
Fierce Pharma
Sun, 09/10/17 - 11:43 am
ESMO
AstraZeneca
Imfinzi
lung cancer
AstraZeneca targeting California-based Acadia Pharmaceuticals ($4.4bn)
GoInPharma
Sun, 09/10/17 - 11:34 am
AstraZeneca
M&A
Acadia
ESMO: AstraZeneca's Tagrisso bests rivals at holding off EGFR lung cancer growth
Fierce Pharma
Sat, 09/9/17 - 03:05 pm
AstraZeneca
ESMO
Tagrisso
AstraZeneca, Amgen whip up some blockbuster excitement with a possible game-changing asthma drug
Endpoints
Thu, 09/7/17 - 09:33 am
AstraZeneca
Amgen
tezepelumab
asthma
Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
Yahoo/Zacks.com
Sat, 09/2/17 - 11:11 am
Parkinson's Disease
Novartis
Teva Pharmaceutial
UCB Pharma
MEDI1341
AstraZeneca
Takeda
PRX002
Prothena
Roche
Acorda
Inbrija
Adamas Pharmaceuticals
Gocovri
Daiichi Sankyo douses a report about an AstraZeneca buyout offer
Endpoints
Thu, 08/31/17 - 09:28 am
AstraZeneca
Daiichi Sankyo
M&A
AstraZeneca auctions off rights to another pipeline drug as Takeda grabs $400M Parkinson’s deal
Endpoints
Tue, 08/29/17 - 10:54 am
AstraZeneca
Takeda
MEDI1341
Parkinson's Disease
AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting
Yahoo/Zacks.com
Mon, 08/28/17 - 09:35 am
AstraZeneca
Faslodex
FDA
advanced breast cancer
With two new uses kaput, AstraZeneca touts more long-term Brilinta data at ESC
Fierce Pharma
Thu, 08/24/17 - 11:25 am
AstraZeneca
Brilinta
blood thinners
Pfizer's Ibrance in First-Line Combo Breast Cancer Study
Yahoo/Zacks.com
Wed, 08/23/17 - 11:14 am
Pfizer
Ibrance
breast cancer
Faslodex
AstraZeneca
Struggling AstraZeneca ups the ante on mRNA pipeline work
Endpoints
Mon, 08/21/17 - 09:42 am
AstraZeneca
MRNA
R&D
Ethris
respiratory health
Ovarian Cancer Market Still Up For Grabs
Barron's
Sat, 08/19/17 - 10:48 am
ovarian cancer
Lynparza
Tesaro
AstraZeneca
Clovis Oncology
Pages
« first
‹ previous
…
64
65
66
67
68
69
70
71
72
…
next ›
last »